Intestinal transcriptome analysis showed that mice treated with cancer therapeutics and B. bre JCM92 showed significantly enriched E2F targets, TNF-α signaling via NFκB, inflammatory responses, and IFN-γ responses. This evidence concerns the gene NFKB1 and cancer.